Do analysts rate BNR or AUNA?

Auna has a consensus target price of $6.97, indicating a potential upside of 44.87%. Given Auna's stronger consensus rating and higher possible upside, analysts clearly believe Auna is more favorable than Burning Rock Biotech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Burning Rock Biotech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Auna 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.40

Do analysts rate BNR or SBC?

SBC Medical Group has a consensus price target of $8.50, suggesting a potential upside of 181.46%. Given SBC Medical Group's stronger consensus rating and higher probable upside, analysts clearly believe SBC Medical Group is more favorable than Burning Rock Biotech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Burning Rock Biotech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SBC Medical Group 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Do analysts rate BNR or LFMD?

LifeMD has a consensus target price of $9.14, indicating a potential upside of 83.96%. Given LifeMD's stronger consensus rating and higher probable upside, analysts clearly believe LifeMD is more favorable than Burning Rock Biotech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Burning Rock Biotech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 LifeMD 1 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.70

Does the media refer more to BNR or LFMD?

In the previous week, Burning Rock Biotech and Burning Rock Biotech both had 3 articles in the media. Burning Rock Biotech's average media sentiment score of 1.63 beat LifeMD's score of 0.39 indicating that Burning Rock Biotech is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Burning Rock Biotech 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive LifeMD 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer BNR or BDSX?

Biodesix has a consensus price target of $22.00, indicating a potential upside of 46.57%. Given Biodesix's stronger consensus rating and higher possible upside, analysts clearly believe Biodesix is more favorable than Burning Rock Biotech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Burning Rock Biotech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Biodesix 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Does the media refer more to BNR or BDSX?

In the previous week, Burning Rock Biotech had 1 more articles in the media than Biodesix. MarketBeat recorded 3 mentions for Burning Rock Biotech and 2 mentions for Biodesix. Burning Rock Biotech's average media sentiment score of 1.63 beat Biodesix's score of 1.36 indicating that Burning Rock Biotech is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Burning Rock Biotech 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Biodesix 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend XGN or BNR?

Exagen presently has a consensus price target of $9.25, suggesting a potential upside of 120.76%. Given Exagen's stronger consensus rating and higher possible upside, equities research analysts plainly believe Exagen is more favorable than Burning Rock Biotech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Exagen 1 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.78 Burning Rock Biotech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media prefer XGN or BNR?

In the previous week, Burning Rock Biotech had 1 more articles in the media than Exagen. MarketBeat recorded 3 mentions for Burning Rock Biotech and 2 mentions for Exagen. Burning Rock Biotech's average media sentiment score of 1.63 beat Exagen's score of 1.23 indicating that Burning Rock Biotech is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Exagen 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Burning Rock Biotech 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Burning Rock Biotech (BNR) Competitors

$8.33 +0.15 (+1.83%)

Closing price 06/10/2026 03:59 PM Eastern

Extended Trading

$8.38 +0.04 (+0.54%)

As of 06/10/2026 04:04 PM Eastern

Compare

BNR vs. AUNA, SBC, LFMD, BDSX, and XGN

Should you buy Burning Rock Biotech stock or one of its competitors? MarketBeat compares Burning Rock Biotech with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Burning Rock Biotech include Auna (AUNA), SBC Medical Group (SBC), LifeMD (LFMD), Biodesix (BDSX), and Exagen (XGN). These companies are all part of the "healthcare" industry.

How does Burning Rock Biotech compare to Auna?

Burning Rock Biotech (NASDAQ:BNR) and Auna (NYSE:AUNA) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, valuation, analyst recommendations, media sentiment, profitability and earnings.

In the previous week, Burning Rock Biotech had 3 more articles in the media than Auna. MarketBeat recorded 3 mentions for Burning Rock Biotech and 0 mentions for Auna. Burning Rock Biotech's average media sentiment score of 1.63 beat Auna's score of 0.00 indicating that Burning Rock Biotech is being referred to more favorably in the media.

Company	Overall Sentiment
Burning Rock Biotech	Very Positive
Auna	Neutral

Burning Rock Biotech has a beta of 1.32, indicating that its stock price is 32% more volatile than the broader market. Comparatively, Auna has a beta of 0.81, indicating that its stock price is 19% less volatile than the broader market.

Auna has higher revenue and earnings than Burning Rock Biotech. Burning Rock Biotech is trading at a lower price-to-earnings ratio than Auna, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Burning Rock Biotech	$77.16M	1.14	-$7.92M	-$0.79	N/A
Auna	$1.23B	0.29	$27.39M	$0.26	18.50

30.0% of Burning Rock Biotech shares are held by institutional investors. 30.3% of Burning Rock Biotech shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Auna has a net margin of 1.53% compared to Burning Rock Biotech's net margin of -11.57%. Auna's return on equity of 16.25% beat Burning Rock Biotech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Burning Rock Biotech	-11.57%	-10.89%	-7.31%
Auna	1.53%	16.25%	4.03%

Auna has a consensus target price of $6.97, indicating a potential upside of 44.87%. Given Auna's stronger consensus rating and higher possible upside, analysts clearly believe Auna is more favorable than Burning Rock Biotech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Burning Rock Biotech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Auna	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.40

Summary

Auna beats Burning Rock Biotech on 11 of the 17 factors compared between the two stocks.

How does Burning Rock Biotech compare to SBC Medical Group?

Burning Rock Biotech (NASDAQ:BNR) and SBC Medical Group (NASDAQ:SBC) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, media sentiment, valuation and earnings.

In the previous week, Burning Rock Biotech had 2 more articles in the media than SBC Medical Group. MarketBeat recorded 3 mentions for Burning Rock Biotech and 1 mentions for SBC Medical Group. SBC Medical Group's average media sentiment score of 1.89 beat Burning Rock Biotech's score of 1.63 indicating that SBC Medical Group is being referred to more favorably in the news media.

Company	Overall Sentiment
Burning Rock Biotech	Very Positive
SBC Medical Group	Very Positive

SBC Medical Group has a consensus price target of $8.50, suggesting a potential upside of 181.46%. Given SBC Medical Group's stronger consensus rating and higher probable upside, analysts clearly believe SBC Medical Group is more favorable than Burning Rock Biotech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Burning Rock Biotech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
SBC Medical Group	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

SBC Medical Group has a net margin of 24.09% compared to Burning Rock Biotech's net margin of -11.57%. SBC Medical Group's return on equity of 15.90% beat Burning Rock Biotech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Burning Rock Biotech	-11.57%	-10.89%	-7.31%
SBC Medical Group	24.09%	15.90%	11.61%

30.0% of Burning Rock Biotech shares are owned by institutional investors. Comparatively, 60.8% of SBC Medical Group shares are owned by institutional investors. 30.3% of Burning Rock Biotech shares are owned by company insiders. Comparatively, 81.7% of SBC Medical Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Burning Rock Biotech has a beta of 1.32, indicating that its stock price is 32% more volatile than the broader market. Comparatively, SBC Medical Group has a beta of 0.59, indicating that its stock price is 41% less volatile than the broader market.

SBC Medical Group has higher revenue and earnings than Burning Rock Biotech. Burning Rock Biotech is trading at a lower price-to-earnings ratio than SBC Medical Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Burning Rock Biotech	$77.16M	1.14	-$7.92M	-$0.79	N/A
SBC Medical Group	$173.61M	1.78	$50.99M	$0.39	7.74

Summary

SBC Medical Group beats Burning Rock Biotech on 14 of the 16 factors compared between the two stocks.

How does Burning Rock Biotech compare to LifeMD?

Burning Rock Biotech (NASDAQ:BNR) and LifeMD (NASDAQ:LFMD) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, profitability, media sentiment and earnings.

30.0% of Burning Rock Biotech shares are held by institutional investors. Comparatively, 35.5% of LifeMD shares are held by institutional investors. 30.3% of Burning Rock Biotech shares are held by company insiders. Comparatively, 18.4% of LifeMD shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Burning Rock Biotech and Burning Rock Biotech both had 3 articles in the media. Burning Rock Biotech's average media sentiment score of 1.63 beat LifeMD's score of 0.39 indicating that Burning Rock Biotech is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Burning Rock Biotech	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
LifeMD	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

LifeMD has higher revenue and earnings than Burning Rock Biotech. Burning Rock Biotech is trading at a lower price-to-earnings ratio than LifeMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Burning Rock Biotech	$77.16M	1.14	-$7.92M	-$0.79	N/A
LifeMD	$194.05M	1.24	$14.35M	$0.05	99.40

Burning Rock Biotech has a beta of 1.32, suggesting that its share price is 32% more volatile than the broader market. Comparatively, LifeMD has a beta of 1.98, suggesting that its share price is 98% more volatile than the broader market.

LifeMD has a consensus target price of $9.14, indicating a potential upside of 83.96%. Given LifeMD's stronger consensus rating and higher probable upside, analysts clearly believe LifeMD is more favorable than Burning Rock Biotech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Burning Rock Biotech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
LifeMD	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.70

LifeMD has a net margin of 2.37% compared to Burning Rock Biotech's net margin of -11.57%. Burning Rock Biotech's return on equity of -10.89% beat LifeMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Burning Rock Biotech	-11.57%	-10.89%	-7.31%
LifeMD	2.37%	-150.88%	-22.59%

Summary

LifeMD beats Burning Rock Biotech on 11 of the 15 factors compared between the two stocks.

How does Burning Rock Biotech compare to Biodesix?

Burning Rock Biotech (NASDAQ:BNR) and Biodesix (NASDAQ:BDSX) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, valuation, earnings, dividends, analyst recommendations and risk.

Biodesix has a consensus price target of $22.00, indicating a potential upside of 46.57%. Given Biodesix's stronger consensus rating and higher possible upside, analysts clearly believe Biodesix is more favorable than Burning Rock Biotech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Burning Rock Biotech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Biodesix	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Burning Rock Biotech has a net margin of -11.57% compared to Biodesix's net margin of -33.26%. Burning Rock Biotech's return on equity of -10.89% beat Biodesix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Burning Rock Biotech	-11.57%	-10.89%	-7.31%
Biodesix	-33.26%	-2,101.40%	-35.65%

Burning Rock Biotech has higher earnings, but lower revenue than Biodesix. Burning Rock Biotech is trading at a lower price-to-earnings ratio than Biodesix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Burning Rock Biotech	$77.16M	1.14	-$7.92M	-$0.79	N/A
Biodesix	$88.50M	1.76	-$35.26M	-$4.06	N/A

In the previous week, Burning Rock Biotech had 1 more articles in the media than Biodesix. MarketBeat recorded 3 mentions for Burning Rock Biotech and 2 mentions for Biodesix. Burning Rock Biotech's average media sentiment score of 1.63 beat Biodesix's score of 1.36 indicating that Burning Rock Biotech is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Burning Rock Biotech	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Biodesix	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Burning Rock Biotech has a beta of 1.32, meaning that its stock price is 32% more volatile than the broader market. Comparatively, Biodesix has a beta of 0.59, meaning that its stock price is 41% less volatile than the broader market.

30.0% of Burning Rock Biotech shares are held by institutional investors. Comparatively, 21.0% of Biodesix shares are held by institutional investors. 30.3% of Burning Rock Biotech shares are held by company insiders. Comparatively, 23.2% of Biodesix shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Burning Rock Biotech beats Biodesix on 10 of the 16 factors compared between the two stocks.

How does Burning Rock Biotech compare to Exagen?

Exagen (NASDAQ:XGN) and Burning Rock Biotech (NASDAQ:BNR) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, institutional ownership, media sentiment, valuation and risk.

Exagen has a beta of 2.02, suggesting that its stock price is 102% more volatile than the broader market. Comparatively, Burning Rock Biotech has a beta of 1.32, suggesting that its stock price is 32% more volatile than the broader market.

Exagen presently has a consensus price target of $9.25, suggesting a potential upside of 120.76%. Given Exagen's stronger consensus rating and higher possible upside, equities research analysts plainly believe Exagen is more favorable than Burning Rock Biotech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Exagen	1 Sell rating(s)	0 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.78
Burning Rock Biotech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

75.3% of Exagen shares are owned by institutional investors. Comparatively, 30.0% of Burning Rock Biotech shares are owned by institutional investors. 10.4% of Exagen shares are owned by insiders. Comparatively, 30.3% of Burning Rock Biotech shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Burning Rock Biotech had 1 more articles in the media than Exagen. MarketBeat recorded 3 mentions for Burning Rock Biotech and 2 mentions for Exagen. Burning Rock Biotech's average media sentiment score of 1.63 beat Exagen's score of 1.23 indicating that Burning Rock Biotech is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Exagen	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Burning Rock Biotech	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Burning Rock Biotech has higher revenue and earnings than Exagen. Burning Rock Biotech is trading at a lower price-to-earnings ratio than Exagen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Exagen	$66.57M	1.52	-$19.95M	-$0.89	N/A
Burning Rock Biotech	$77.16M	1.14	-$7.92M	-$0.79	N/A

Burning Rock Biotech has a net margin of -11.57% compared to Exagen's net margin of -29.49%. Burning Rock Biotech's return on equity of -10.89% beat Exagen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Exagen	-29.49%	-94.37%	-28.96%
Burning Rock Biotech	-11.57%	-10.89%	-7.31%

Summary

Burning Rock Biotech beats Exagen on 9 of the 16 factors compared between the two stocks.

Get Burning Rock Biotech News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BNR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BNR vs. The Competition

Export

Metric	Burning Rock Biotech	Technology Services Industry	Business Sector	NASDAQ Exchange
Market Cap	$86.04M	$3.96B	$6.59B	$11.95B
Dividend Yield	N/A	2.14%	3.11%	5.61%
P/E Ratio	-10.16	39.50	27.45	23.63
Price / Sales	1.14	45.30	398.31	104.15
Price / Cash	N/A	39.05	23.44	54.72
Price / Book	1.14	4.61	5.73	6.70
Net Income	-$7.92M	$31.68M	$202.45M	$337.26M
7 Day Performance	-9.06%	-7.39%	-3.08%	-2.43%
1 Month Performance	-48.61%	-6.26%	-0.89%	0.19%
1 Year Performance	176.74%	17.43%	29.71%	23.15%

Burning Rock Biotech Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BNR Burning Rock Biotech	1.7214 of 5 stars	$8.33 +1.8%	N/A	+157.1%	$86.04M	$77.16M	N/A	1,390	News Coverage Positive News Earnings Report
AUNA Auna	4.7615 of 5 stars	$4.52 -0.6%	$6.97 +54.3%	-23.9%	$336.02M	$1.23B	17.37	15,254	Gap Up
SBC SBC Medical Group	3.9574 of 5 stars	$3.20 -0.3%	$8.50 +165.6%	-36.8%	$329.27M	$173.61M	8.21	N/A	Positive News
LFMD LifeMD	3.0833 of 5 stars	$4.69 +1.3%	$9.14 +94.9%	-59.1%	$223.92M	$194.05M	93.82	230
BDSX Biodesix	3.7792 of 5 stars	$15.44 +1.1%	$22.00 +42.5%	+127.4%	$158.13M	$88.50M	N/A	220	Positive News Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BNR) was last updated on 6/11/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Burning Rock Biotech (BNR) Competitors

BNR vs. AUNA, SBC, LFMD, BDSX, and XGN

How does Burning Rock Biotech compare to Auna?

Summary

How does Burning Rock Biotech compare to SBC Medical Group?

Summary

How does Burning Rock Biotech compare to LifeMD?

Summary

How does Burning Rock Biotech compare to Biodesix?

Summary

How does Burning Rock Biotech compare to Exagen?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BNR vs. The Competition

Burning Rock Biotech Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Burning Rock Biotech (BNR) Competitors

BNR vs. AUNA, SBC, LFMD, BDSX, and XGN

How does Burning Rock Biotech compare to Auna?

Does the media refer more to BNR or AUNA?

Which has more volatility & risk, BNR or AUNA?

Which has stronger valuation & earnings, BNR or AUNA?

Do insiders and institutionals have more ownership in BNR or AUNA?

Is BNR or AUNA more profitable?

Do analysts rate BNR or AUNA?

Summary

How does Burning Rock Biotech compare to SBC Medical Group?

Does the media refer more to BNR or SBC?

Do analysts rate BNR or SBC?

Is BNR or SBC more profitable?

Do institutionals & insiders hold more shares of BNR or SBC?

Which has more risk and volatility, BNR or SBC?

Which has stronger earnings & valuation, BNR or SBC?

Summary

How does Burning Rock Biotech compare to LifeMD?

Do institutionals and insiders have more ownership in BNR or LFMD?

Does the media refer more to BNR or LFMD?

Which has higher valuation and earnings, BNR or LFMD?

Which has more risk & volatility, BNR or LFMD?

Do analysts rate BNR or LFMD?

Is BNR or LFMD more profitable?

Summary

How does Burning Rock Biotech compare to Biodesix?

Do analysts prefer BNR or BDSX?

Is BNR or BDSX more profitable?

Which has higher earnings and valuation, BNR or BDSX?

Does the media refer more to BNR or BDSX?

Which has more risk & volatility, BNR or BDSX?

Do institutionals & insiders believe in BNR or BDSX?

Summary

How does Burning Rock Biotech compare to Exagen?

Which has more volatility and risk, XGN or BNR?

Do analysts recommend XGN or BNR?

Do institutionals and insiders hold more shares of XGN or BNR?

Does the media prefer XGN or BNR?

Which has better earnings & valuation, XGN or BNR?

Is XGN or BNR more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BNR vs. The Competition

Burning Rock Biotech Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools